Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Punishment

Punishment

Negative reinforcement and punishment are often confused but serve distinct functions in behavior modification. Reinforcement, whether positive or negative, increases the likelihood of a desired behavior, while punishment decreases it.
Punishment can be positive or negative. Positive punishment involves adding an undesirable stimulus, such as scolding, to decrease a behavior. Negative punishment involves removing a desirable stimulus, such as taking away a favorite toy, to decrease behavior.

Ending Relationships

Ending Relationships

The dissolution of intimate relationships presents complex emotional and psychological challenges, particularly when emotional bonds are strong, the relationship is long-standing, and perceived alternatives are limited. This distress often intensifies in romantic breakups, where the initiator may experience greater turmoil than the rejected partner. Contributing factors include residual attachment, guilt over causing pain, and uncertainty about how to manage the situation. The stress is further...

Electric Dipoles and Dipole Moment

Electric Dipoles and Dipole Moment

Consider two charges of equal magnitude but opposite signs. If they cannot be separated by an external electric field, the system is called a permanent dipole. For example, the water molecule is a dipole, making it a good solvent.
Theoretically, studying electric dipoles leads to understanding why the resultant electric forces around us are weak. Since electric forces are strong, remnant net charges are rare. Hence, the interaction between dipoles helps us understand electrical interactions in...

Cardiomyopathy II: Dilated Cardiomyopathy

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...

Depressive Disorders: MDD and Dysthymia

Depressive Disorders: MDD and Dysthymia

Depressive disorders are a group of mental health conditions characterized by pervasive feelings of sadness, diminished pleasure in life, and a significant impact on daily functioning. These conditions are most prevalent in individuals during their 30s and affect women at twice the rate of men. Contrary to popular belief, younger individuals are generally more susceptible to these disorders than older adults. Two key types of depressive disorders include Major Depressive Disorder (MDD) and...

Diamagnetism

Diamagnetism

Materials consisting of paired electrons have zero net magnetic moments. However, when these materials are placed under an external magnetic field, the moments opposite to the field are induced. Such materials are called diamagnets. Diamagnetism is the response of the diamagnets when placed in an external magnetic field.
Diamagnetism was discovered by Anton Brugmans in 1778 when he observed that bismuth gets repelled by magnetic fields, thus theorizing that diamagnets get repelled by magnets.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Cognitive reserve and its impact on cognitive and functional abilities, physical activity and quality of life following a diagnosis of dementia: longitudinal findings from the Improving the experience of Dementia and Enhancing Active Life (IDEAL) study.

Age and ageing·2025

Same author

Differences in trajectories of quality of life according to type of dementia: 6-year longitudinal findings from the IDEAL programme.

BMC medicine·2024

Same author

Health conditions in spousal caregivers of people with dementia and their relationships with stress, caregiving experiences, and social networks: longitudinal findings from the IDEAL programme.

BMC geriatrics·2024

Same author

Comorbid health conditions and their impact on social isolation, loneliness, quality of life, and well-being in people with dementia: longitudinal findings from the IDEAL programme.

BMC geriatrics·2024

Same author

Dyadic perspectives on loneliness and social isolation among people with dementia and spousal carers: findings from the IDEAL programme.

Aging & mental health·2023

Same author

"Living Well" Trajectories Among Family Caregivers of People With Mild-to-Moderate Dementia in the IDEAL Cohort.

The journals of gerontology. Series B, Psychological sciences and social sciences·2022

Same journal

The potential of key Alzheimer's plasma biomarkers to mimic tau PET MUBADA-based disease staging.

Alzheimer's research & therapy·2026

Same journal

Smoking cessation duration and risk of Alzheimer's disease: a nationwide cohort study in Korea.

Alzheimer's research & therapy·2026

Same journal

Lecanemab in practice: AI-derived MRI predictors of benefit and Amyloid Related Imaging Abnormalities (ARIA).

Alzheimer's research & therapy·2026

Same journal

Structural and molecular determinants of medial temporal lobe network vulnerability in aging and Alzheimer's disease.

Alzheimer's research & therapy·2026

Same journal

Facial phenotypes in Alzheimer's disease: from neurobiology to artificial intelligence.

Alzheimer's research & therapy·2026

Same journal

Neural changes after computerized cognitive training in coronary heart disease with mild cognitive impairment: secondary analysis of a randomized clinical trial.

Alzheimer's research & therapy·2026

See all related articles

Search research articles

Related Experiment Video

Updated: Jun 8, 2026

Animal Models of Depression - Chronic Despair Model (CDM)

Animal Models of Depression - Chronic Despair Model (CDM)

Published on: September 23, 2021

Dimebon disappointment.

¹Research Institute for the Care of Older People, Royal United Hospital, Bath BA1 3NG, UK. r.w.jones@bath.ac.uk.

Alzheimer'S Research & Therapy

|September 15, 2010

Summary

This summary is machine-generated.

Dimebon (latrepirdine) showed promise for Alzheimer's disease in a phase 2 trial but failed to demonstrate efficacy in a larger phase 3 study. Further research is needed to understand these conflicting results for Alzheimer's drug development.

More Related Videos

Displacement Analysis of Myocardial Mechanical Deformation (DIAMOND) Reveals Segmental Heterogeneity of Cardiac Function in Embryonic Zebrafish

Displacement Analysis of Myocardial Mechanical Deformation (DIAMOND) Reveals Segmental Heterogeneity of Cardiac Function in Embryonic Zebrafish

Published on: February 6, 2020

A Procedure for Studying the Footshock-Induced Reinstatement of Cocaine Seeking in Laboratory Rats

A Procedure for Studying the Footshock-Induced Reinstatement of Cocaine Seeking in Laboratory Rats

Published on: January 6, 2011

Related Experiment Videos

Last Updated: Jun 8, 2026

Animal Models of Depression - Chronic Despair Model (CDM)

Animal Models of Depression - Chronic Despair Model (CDM)

Published on: September 23, 2021

Displacement Analysis of Myocardial Mechanical Deformation (DIAMOND) Reveals Segmental Heterogeneity of Cardiac Function in Embryonic Zebrafish

Displacement Analysis of Myocardial Mechanical Deformation (DIAMOND) Reveals Segmental Heterogeneity of Cardiac Function in Embryonic Zebrafish

Published on: February 6, 2020

A Procedure for Studying the Footshock-Induced Reinstatement of Cocaine Seeking in Laboratory Rats

A Procedure for Studying the Footshock-Induced Reinstatement of Cocaine Seeking in Laboratory Rats

Published on: January 6, 2011

Area of Science:

Neuroscience
Pharmacology
Clinical Trials

Background:

Dimebon (latrepirdine) gained attention for Alzheimer's disease (AD) after a positive Russian phase 2 study reported cognitive, functional, and behavioral improvements.
The phase 2 study indicated sustained benefits up to 12 months in cognition and daily function.

Discussion:

A subsequent multinational phase 3 trial yielded disappointing results, showing no significant difference between dimebon and placebo groups.
The phase 3 study observed minimal deterioration across all groups, contrasting with the phase 2 placebo group's decline.

Key Insights:

Conflicting outcomes between phase 2 and phase 3 trials necessitate a thorough investigation into the reasons for dimebon's lack of efficacy.
The discrepancy highlights challenges in Alzheimer's disease clinical trial design and interpretation.

Outlook:

Further analysis is crucial to understand the variability in dimebon's effects and its implications for future Alzheimer's drug development.
This case underscores the importance of rigorous, large-scale trials in validating potential therapies for neurodegenerative diseases.